BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29721766)

  • 1. Radiotherapy volume delineation using 18F-FDG-PET/CT modifies gross node volume in patients with oesophageal cancer.
    Jimenez-Jimenez E; Mateos P; Aymar N; Roncero R; Ortiz I; Gimenez M; Pardo J; Salinas J; Sabater S
    Clin Transl Oncol; 2018 Nov; 20(11):1460-1466. PubMed ID: 29721766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radiotherapy volume delineation based on (
    Encaoua J; Abgral R; Leleu C; El Kabbaj O; Caradec P; Bourhis D; Pradier O; Schick U
    Cancer Radiother; 2017 Jun; 21(4):267-275. PubMed ID: 28499658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.
    Dong X; Wu P; Sun X; Li W; Wan H; Yu J; Xing L
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):338-45. PubMed ID: 25708154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour delineation in oesophageal cancer - A prospective study of delineation in PET and CT with and without endoscopically placed clip markers.
    Thomas L; Lapa C; Bundschuh RA; Polat B; Sonke JJ; Guckenberger M
    Radiother Oncol; 2015 Aug; 116(2):269-75. PubMed ID: 26364886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of target volumes defined by deformable and rigid registration of diagnostic PET/CT to planning CT in primary esophageal cancer.
    Guo Y; Li J; Zhang P; Shao Q; Xu M; Li Y
    Medicine (Baltimore); 2017 Jan; 96(1):e5528. PubMed ID: 28072693
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Zhao L; Chen S; Chen S; Pang Y; Dai Y; Hu S; Lin L; Fu L; Sun L; Wu H; Chen H; Lin Q
    Radiother Oncol; 2021 May; 158():55-61. PubMed ID: 33621587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of (18)F-fluorothymidine and (18)F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus.
    Han D; Yu J; Yu Y; Zhang G; Zhong X; Lu J; Yin Y; Fu Z; Mu D; Zhang B; He W; Huo Z; Liu X; Kong L; Zhao S; Sun X
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1235-41. PubMed ID: 19910143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [F18] FDG-PET/CT for manual or semiautomated GTV delineation of the primary tumor for radiation therapy planning in patients with esophageal cancer: is it useful?
    Walter F; Jell C; Zollner B; Andrae C; Gerum S; Ilhan H; Belka C; Niyazi M; Roeder F
    Strahlenther Onkol; 2021 Sep; 197(9):780-790. PubMed ID: 33104815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical application of 4D 18F-FDG PET/CT on gross tumor volume delineation for radiotherapy planning in esophageal squamous cell cancer.
    Wang YC; Hsieh TC; Yu CY; Yen KY; Chen SW; Yang SN; Chien CR; Hsu SM; Pan T; Kao CH; Liang JA
    J Radiat Res; 2012 Jul; 53(4):594-600. PubMed ID: 22843625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geometrical differences in target volumes based on 18F-fluorodeoxyglucose positron emission tomography/computed tomography and four-dimensional computed tomography maximum intensity projection images of primary thoracic esophageal cancer.
    Guo Y; Li J; Wang W; Zhang Y; Wang J; Duan Y; Shang D; Fu Z
    Dis Esophagus; 2014; 27(8):744-50. PubMed ID: 24915760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving observer variability in target delineation for gastro-oesophageal cancer--the role of (18F)fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography.
    Vesprini D; Ung Y; Dinniwell R; Breen S; Cheung F; Grabarz D; Kamra J; Mah K; Mansouri A; Pond G; Brock K; Darling G; Knox J; Haider M; Wong RK
    Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):631-8. PubMed ID: 18755578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer.
    Muijs CT; Beukema JC; Pruim J; Mul VE; Groen H; Plukker JT; Langendijk JA
    Radiother Oncol; 2010 Nov; 97(2):165-71. PubMed ID: 20541273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET definition of gross tumor volume for radiotherapy of lung cancer: is the tumor uptake value-based approach appropriate for lymph node delineation?
    Rodríguez N; Sanz X; Trampal C; Foro P; Reig A; Lacruz M; Membrive I; Lozano J; Quera J; Algara M
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):659-66. PubMed ID: 20133071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer.
    Leong T; Everitt C; Yuen K; Condron S; Hui A; Ngan SY; Pitman A; Lau EW; MacManus M; Binns D; Ackerly T; Hicks RJ
    Radiother Oncol; 2006 Mar; 78(3):254-61. PubMed ID: 16545881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of 18-fluorodeoxyglucose positron emission tomography on computed tomography defined target volumes in radiation treatment planning of esophageal cancer: reduction in geographic misses with equal inter-observer variability: PET/CT improves esophageal target definition.
    Schreurs LM; Busz DM; Paardekooper GM; Beukema JC; Jager PL; Van der Jagt EJ; van Dam GM; Groen H; Plukker JT; Langendijk JA
    Dis Esophagus; 2010 Aug; 23(6):493-501. PubMed ID: 20113320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma.
    Moureau-Zabotto L; Touboul E; Lerouge D; Deniaud-Alexandre E; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Kerrou K; Montravers F; Keraudy K; Tiret E; Gendre JP; Grange JD; Houry S; Talbot JN
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):340-5. PubMed ID: 16168829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delineation of lung cancer with FDG PET/CT during radiation therapy.
    Ganem J; Thureau S; Gardin I; Modzelewski R; Hapdey S; Vera P
    Radiat Oncol; 2018 Nov; 13(1):219. PubMed ID: 30419929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating diffusion-weighted magnetic resonance imaging for target volume delineation in head and neck radiotherapy.
    Cardoso M; Min M; Jameson M; Tang S; Rumley C; Fowler A; Estall V; Pogson E; Holloway L; Forstner D
    J Med Imaging Radiat Oncol; 2019 Jun; 63(3):399-407. PubMed ID: 30816646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory-gated (4D) contrast-enhanced FDG PET-CT for radiotherapy planning of lower oesophageal carcinoma: feasibility and impact on planning target volume.
    Scarsbrook A; Ward G; Murray P; Goody R; Marshall K; McDermott G; Prestwich R; Radhakrishna G
    BMC Cancer; 2017 Oct; 17(1):671. PubMed ID: 28978306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Time-Phase Effect on 18F-FDG PET/CT Delineation Methods for Treatment Planning of Nasopharyngeal Carcinoma.
    Chen YZ; Li WF; Wang JY; Wang JM; Ou RY; Zheng XW; Xu YS; Zhao L
    Clin Nucl Med; 2016 May; 41(5):354-61. PubMed ID: 26859212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.